Parkinson's Disease Research

Parkinson's disease (PD) is a degenerative disease of the central nervous system that often impairs motor skills, speech, and other functions. Symptoms of the disease include resting tremor, bradykinesia and rigidity. The primary symptoms are the result of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Symptoms of the disease appear once 50-80% of dopamine neurons have died. Parkinson's disease is both chronic and progressive.

Parkinson's Disease Research Products Targets

Products for Parkinson's Disease Research - Page 40

  1. Cat.No. Product Name Information/Activity
  2. BCC7250 (R)-(-)-Apomorphine hydrochloride 314-19-2 (R)-(-)-Apomorphine hydrochloride chemical structure
  3. BCC6991 CY 208-243 CY 208-243 is a selective dopamine D1 receptor agonist which exhibits antiparkinsonian activity. CY 208-243 chemical structure
  4. BCC5681 Dihydrexidine hydrochloride (+)-Dihydrexidine hydrochloride ((+)-DAR-0100 hydrochloride) is a dopamine D1 receptor agonist with an EC50 of 72± 21 nM. Dihydrexidine hydrochloride chemical structure
  5. BCC7837 NPEC-caged-dopamine 1257326-23-0 NPEC-caged-dopamine chemical structure
  6. BCC6848 SKF 38393 hydrobromide 20012-10-6 SKF 38393 hydrobromide chemical structure
  7. BCC7144 SKF 77434 hydrobromide 300561-58-4 SKF 77434 hydrobromide chemical structure
  8. BCC7071 SKF 81297 hydrobromide 67287-39-2 SKF 81297 hydrobromide chemical structure
  9. BCC7252 SKF 83822 hydrobromide 74115-10-9 SKF 83822 hydrobromide chemical structure
  10. BCC7251 SKF 83959 hydrobromide 67287-95-0 SKF 83959 hydrobromide chemical structure
  11. BCC7148 LE 300 274694-98-3 LE 300 chemical structure

Items 391 to 400 of 752 total